These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Viral ribonuclei acid synthesis by Newcastle disease virus mutants isolated from persistently infected L cells: effect of interferon. Thacore HR, Youngner JS. J Virol; 1972 Mar; 9(3):503-9. PubMed ID: 5062750 [Abstract] [Full Text] [Related]
44. Antigenomes in Sendai virions and Sendai virus-infected cells. Kolakofsky D, Bruschi A. Virology; 1975 Jul; 66(1):185-91. PubMed ID: 166498 [No Abstract] [Full Text] [Related]
45. [Effect of cycloheximide on synthesis of complementary virus-specific RNA in cells infected with Newcastle disease virus]. Kaverin NV, Varich NL. Vopr Virusol; 1972 Jul; 17(1):55-9. PubMed ID: 5062525 [No Abstract] [Full Text] [Related]
46. The participation of sendai virus ribonucleoprotein in virus-specific polysome formation. Bukrinskaya AG, Bykovsky AP, Zhdanov VM. Virology; 1969 Dec; 39(4):705-20. PubMed ID: 4311637 [No Abstract] [Full Text] [Related]
47. Interaction of viral RNA with Escherichia coli. II. Synthesis of poliovirus-specific RNA directed by poliovirus RF-RNA. Koch G, Vollertsen I. Arch Biochem Biophys; 1972 Oct; 152(2):475-87. PubMed ID: 4344125 [No Abstract] [Full Text] [Related]
48. Degradation of cellular ribonucleic acid in Newcastle disease virus infected cells. Huo WH, Wilson DE. J Gen Virol; 1969 Mar; 4(2):245-51. PubMed ID: 5772489 [No Abstract] [Full Text] [Related]
53. Location and abundance of poly (A) sequences in Sendai virus messenger RNA molecules. Marx PA, Pridgen C, Kingsbury DW. J Gen Virol; 1975 May; 27(2):247-50. PubMed ID: 167113 [Abstract] [Full Text] [Related]
54. [Functioning of Sendai virus ribonucleoprotein in cells of permissive systems]. Pashova VA, Bukrinskaia AG. Vopr Virusol; 1974 May; (1):65-71. PubMed ID: 4374813 [No Abstract] [Full Text] [Related]
55. [Change in the rate of synthesis of types of virus-specific RNA in the course of the reproduction cycle of Newcastle disease virus]. Varich NL, Kaverin NV. Vopr Virusol; 1972 May; 17(6):666-9. PubMed ID: 4664094 [No Abstract] [Full Text] [Related]
56. The effect of actinomycin D on the synthesis of influenza virus-specific RNA. Sugiura A, Ueda M, Enomoto C. Arch Gesamte Virusforsch; 1969 May; 26(1):105-17. PubMed ID: 4890919 [No Abstract] [Full Text] [Related]
57. Comparison of 6-94 virus and Sendai virus RNA by RNA-RNA hybridization. Kolakofsky D, Spahr PF, Koprowski H. J Virol; 1974 Apr; 13(4):935-6. PubMed ID: 4362518 [Abstract] [Full Text] [Related]
58. [Synthesis of complementary virus-induced RNA in 2 strains of Newcastle disease virus]. Kaverin NV, Varich NL. Vopr Virusol; 1971 Apr; 16(6):693-7. PubMed ID: 5168876 [No Abstract] [Full Text] [Related]
59. Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics. Scholtissek C, Rott R. Virology; 1970 Apr; 40(4):989-96. PubMed ID: 5464584 [No Abstract] [Full Text] [Related]
60. Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNA. Oberg B. Biochim Biophys Acta; 1970 Apr 15; 204(2):430-40. PubMed ID: 4315015 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]